Lucentis to Treat Pigment Epithelial Detachment

NCT00841581 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Pigment Epithelial Detachment

Interventions

DRUG: Ranibizumab

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators

[object Object]